Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy

Archives of Ophthalmology

Volumn 126, Issue 8, 2008, Pages 1152-1156

  Benevento, Joseph D ^b   Jager, Rama D ^b   Noble, A Gwendolyn ^b   Latkany, Paul ^b   Mieler, William F ^b   Sautter, Mari ^b   Meyers, Sanford ^b   Mets, Marilyn ^b   Grassi, Michael A ^b   Rabiah, Peter ^b   Boyer, Kenneth ^b   Swisher, Charles ^b   McLeod, Rima ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; FOLINIC ACID; PYRIMETHAMINE; RANIBIZUMAB; STEROID; SULFADIAZINE;

ADULT; ARTICLE; CASE REPORT; CHORIORETINITIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EYE EXAMINATION; HUMAN; LABORATORY TEST; MALE; OCULOPLETHYSMOGRAPHY; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA HEMORRHAGE; SCHOOL CHILD; SUBRETINAL NEOVASCULARIZATION; TOXOPLASMA; TOXOPLASMOSIS; VISUAL ACUITY;

ADULT; ANTIBODIES, MONOCLONAL; ANTIPROTOZOAL AGENTS; CHILD; CHOROIDAL NEOVASCULARIZATION; DRUG THERAPY, COMBINATION; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; LEUCOVORIN; MALE; PYRIMETHAMINE; RETINAL HEMORRHAGE; SULFADIAZINE; TOMOGRAPHY, OPTICAL COHERENCE; TOXOPLASMOSIS, OCULAR; VISUAL ACUITY; VITREOUS BODY;

EID: 49449116334     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.8.1152     Document Type: Article

References (17)

1. Fine SL, Owens SL, Haller JA, Knox DL, Patz A. Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol. 1981;91(3):318-322.
2. Cotliar AM, Friedman AH. Subretinal neovascularisation in ocular toxoplasmosis. Br J Ophthalmol. 1982;66(8):524-529.
3. Kayazawa F. Subretinal neovascularization associated with presumed toxoplasmic retinochoroidal scar. Ann Ophthalmol. 1982;14(9):819-821.
4. Uemura A, Thomas MA. Visual outcome after surgical removal of choroidal neovascularization in pediatric patients. Arch Ophthalmol. 2000;118(10):1373-1378.
5. Adán A, Mateo C, Wolley-Dod C. Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis. Am J Ophthalmol. 2003;135(3):386-387.
6. Spear W, Chan D, Coppens I, Johnson RS, Giaccia A, Blader IJ. The host cell transcription factor hypoxia-inducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels. Cell Microbiol. 2006;8(2):339-352.
7. Wirthlin R, Song A, Song J, Rosenfeld PJ. Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis. Arch Ophthalmol. 2006;124(5):741-743.
8. Mauget-Faÿsse M, Mimoun G, Ruiz-Moreno JM, et al. Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis. Retina. 2006;26(4):396-403.
9. Nessi F, Guex-Crosier Y, Ambresin A, Aografos L. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to toxoplasmic chorioretinal scar. Klin Monatsbl Augenheilkd. 2004;221(5):371-373.
10. Oliveira LB, Reis PA. Photodynamic therapy-treated choroidal neovascular membrane secondary to toxoplasmic retinochoroiditis. Graefes Arch Clin Exp Ophthalmol. 2004;242(12):1028-1030.
11. Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 1996;122(3):309-324.
12. Gaynon MW, Boldrey EE, Strahlman ER, Fine SL. Retinal neovascularization and ocular toxoplasmosis. Am J Ophthalmol. 1984;98(5):585-589.
13. Lafaut BA, Meire FM, Leys AM, Dralands F, De Laey JJ. Vasoproliferative retinal tumors associated with peripheral chorioretinal scars in presumed congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol. 1999;237(12):1033-1038.
14. Bosch-Driessen LH, Plaisier MB, Stilma JS, Van der Lelij A, Rothova A. Reactivations of ocular toxoplasmosis after cataract extraction. Ophthalmology. 2002;109(1):41-45.
15. Fontaine F, Fourmaux E, Colin J. Reactivation of ocular toxoplasmosis after laser in situ keratomileusis [in French]. J Fr Ophtalmol. 2006;29(5):e11.
16. Barbara A, Shehadeh-Masha'our R, Sartani G, Garzozi HJ. Reactivation of ocular toxoplasmosis after LASIK. J Refract Surg. 2005;21(6):759-761.
17. Capone A Jr. Treatment of neovscularization in infants with retinopathy of prematurity with anti-VEGF: vitreous surgery for retinopathy of prematurity. Paper presented at: Annual Meeting of the American Academy of Ophthalmology; November 13, 2006; Las Vegas, NV.